2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1164489241 M.D.
Verify on CMS →

RIM JOUBRAN, M.D.

Endocrinology, Diabetes & Metabolism Physician in MELROSE PARK, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 493 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.2K
44 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RIM JOUBRAN, M.D. filed 4,015 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in MELROSE PARK, Illinois, prescribing 54% generic.

4K
Part D claims, 2023
54%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RIM JOUBRAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

4,015 Top 8% higher than 92% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

RIM JOUBRAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RIM JOUBRAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 05/01/2006

NPI 1164489241

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

4,015 52% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Illinois

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Illinois providers

Illinois providers

Endocrinology, Diabetes & Metabolism Physician share within Illinois

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Illinois

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RIM JOUBRAN, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 675 W NORTH AVE, MELROSE PARK, IL, 60160, with a listed phone of (708) 681-7695. NPI 1164489241 was issued on 05/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JOUBRAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,015 prescription claims written by this provider, covering 493 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 46% brand-name and 54% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

675 W NORTH AVE
MELROSE PARK, IL 60160

Provider Details

NPI 1164489241
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 05/01/2006

Hospital and facility affiliations

Facilities where RIM JOUBRAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

RUSH OAK PARK PHYSICIANS GROUP CENTER FOR DIABETES AND ENDOCRINE
OAK PARK, IL
RUSH UNIVERSITY MEDICAL GROUP
OAK PARK, IL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RIM JOUBRAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

BETA BIONICS, INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Illinois IDFPR 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to RIM JOUBRAN, M.D.. To verify RIM JOUBRAN, M.D.'s current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

RIM JOUBRAN, M.D. — brand share 46.0%
Specialty average (est.)

46% brand-name claims vs 54% generic, on 4,015 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,015
Total Claims
$1.8M
Total Drug Cost
493
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,987
Total Day Supply
236,057
Brand vs Generic
46% brand / 54% generic
Brand Drug Cost
$1.5M
Generic Drug Cost
$46K

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.52
Gender Split
72% female / 28% male
Age Distribution
<65: 61, 65-74: 216, 75-84: 176, 85+: 40

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RIM JOUBRAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
467
Alendronate Sodium
273
Ozempic
Semaglutide
241
Atorvastatin Calcium
220
Jardiance
Empagliflozin
159
Methimazole
136
Humalog
Insulin Lispro
130
Metformin Hcl
128
Trulicity
Dulaglutide
127
Novolog Flexpen
Insulin Aspart
120

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How RIM JOUBRAN, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

RIM JOUBRAN, M.D.'s 4,015 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as JOUBRAN.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RIM JOUBRAN, M.D.'s specialty?
RIM JOUBRAN, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MELROSE PARK, Illinois. Credentials: M.D..
How much does RIM JOUBRAN, M.D. prescribe under Medicare Part D?
In 2023, RIM JOUBRAN, M.D. wrote 4,015 Medicare Part D claims totaling $1.8M in drug costs for 493 beneficiaries.
Where is RIM JOUBRAN, M.D. located?
RIM JOUBRAN, M.D. is located at 675 W NORTH AVE, MELROSE PARK, IL, 60160. Phone: (708) 681-7695.
What is RIM JOUBRAN, M.D.'s NPI number?
RIM JOUBRAN, M.D.'s National Provider Identifier (NPI) is 1164489241, issued on 05/01/2006.
Does RIM JOUBRAN, M.D. prescribe more brand-name or generic drugs?
RIM JOUBRAN, M.D.'s prescribing is 46% brand-name and 54% generic drugs by claim count, with $1.5M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does RIM JOUBRAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RIM JOUBRAN, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Alendronate Sodium, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RIM JOUBRAN, M.D. accept Medicare?
RIM JOUBRAN, M.D. appears in CMS Medicare data with 4,015 Part D claims and 493 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RIM JOUBRAN, M.D.'s credentials?
RIM JOUBRAN, M.D.'s NPI is 1164489241 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology